196 related articles for article (PubMed ID: 25186437)
1. Folate-targeted multifunctional amino acid-chitosan nanoparticles for improved cancer therapy.
Gaspar VM; Costa EC; Queiroz JA; Pichon C; Sousa F; Correia IJ
Pharm Res; 2015 Feb; 32(2):562-77. PubMed ID: 25186437
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
3. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
[TBL] [Abstract][Full Text] [Related]
4. Rapid and soft formulation of folate-functionalized nanoparticles for the targeted delivery of tripentone in ovarian carcinoma.
Tomasina J; Poulain L; Abeilard E; Giffard F; Brotin E; Carduner L; Carreiras F; Gauduchon P; Rault S; Malzert-Fréon A
Int J Pharm; 2013 Dec; 458(1):197-207. PubMed ID: 24084450
[TBL] [Abstract][Full Text] [Related]
5. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
6. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
[TBL] [Abstract][Full Text] [Related]
7. Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy.
Khan MM; Madni A; Filipczak N; Pan J; Rehman M; Rai N; Attia SA; Torchilin VP
Nanomedicine; 2020 Aug; 28():102228. PubMed ID: 32485321
[TBL] [Abstract][Full Text] [Related]
8. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
Zhang C; Zhang Z; Zhao L
Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
[TBL] [Abstract][Full Text] [Related]
9. Phenylboronic Acid-Mediated Tumor Targeting of Chitosan Nanoparticles.
Wang X; Tang H; Wang C; Zhang J; Wu W; Jiang X
Theranostics; 2016; 6(9):1378-92. PubMed ID: 27375786
[TBL] [Abstract][Full Text] [Related]
10. Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment.
Wu Y; Ge P; Xu W; Li M; Kang Q; Zhang X; Xie J
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110386. PubMed ID: 31923940
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier].
Gong JL; Wang SM; Hu XG; Cao MM; Zhang JR
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2183-6. PubMed ID: 19114352
[TBL] [Abstract][Full Text] [Related]
12. Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice.
Hu Z; Chen J; Zhou S; Yang N; Duan S; Zhang Z; Su J; He J; Zhang Z; Lu X; Zhao Y
Theranostics; 2017; 7(7):1942-1952. PubMed ID: 28638480
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumor cells through chitosan-folate modified microcapsules loaded with camptothecin.
Galbiati A; Tabolacci C; Morozzo Della Rocca B; Mattioli P; Beninati S; Paradossi G; Desideri A
Bioconjug Chem; 2011 Jun; 22(6):1066-72. PubMed ID: 21545180
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
15. Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.
Li YJ; Dong M; Kong FM; Zhou JP
Int J Pharm; 2015 Jul; 489(1-2):83-90. PubMed ID: 25888801
[TBL] [Abstract][Full Text] [Related]
16. Environmentally Responsive Dual-Targeting Nanoparticles: Improving Drug Accumulation in Cancer Cells as a Way of Preventing Anticancer Drug Efflux.
Daglioglu C
J Pharm Sci; 2018 Mar; 107(3):934-941. PubMed ID: 29107049
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH
Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251
[TBL] [Abstract][Full Text] [Related]
18. Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method.
Zu Y; Zhao Q; Zhao X; Zu S; Meng L
Int J Nanomedicine; 2011; 6():3429-41. PubMed ID: 22267927
[TBL] [Abstract][Full Text] [Related]
19. Self-folded redox/acid dual-responsive nanocarriers for anticancer drug delivery.
Lu Y; Mo R; Tai W; Sun W; Pacardo DB; Qian C; Shen Q; Ligler FS; Gu Z
Chem Commun (Camb); 2014 Dec; 50(95):15105-8. PubMed ID: 25331017
[TBL] [Abstract][Full Text] [Related]
20. Folate-targeted nanoparticles based on albumin and albumin/alginate mixtures as controlled release systems of tamoxifen: synthesis and in vitro characterization.
Martínez A; Olmo R; Iglesias I; Teijón JM; Blanco MD
Pharm Res; 2014 Jan; 31(1):182-93. PubMed ID: 23921489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
